2024 |
Nuvation Bio Inc - Ordinary Shares - Class A
|
Lead Independent Director |
446.6 K |
0.9 % |
2024 |
Akari Therapeutics Plc - ADR
|
Independent Director |
- |
- |
2024 |
Ardelyx Inc
|
Independent Director |
- |
- |
2023 |
Nuvation Bio Inc - Ordinary Shares - Class A
|
Independent Director |
442.6 K |
883.6 % |
2023 |
Ardelyx Inc
|
Independent Director |
202.4 K |
115.0 % |
2022 |
Ardelyx Inc
|
Independent Director |
94.2 K |
-53.4 % |
2022 |
Nuvation Bio Inc - Warrants (07/07/2027)
|
Independent Director |
45 K |
- |
2022 |
Nuvation Bio Inc - Ordinary Shares - Class A
|
- |
45 K |
-86.8 % |
2021 |
Nuvation Bio Inc - Ordinary Shares - Class A
|
Independent Director |
341.2 K |
- |
2021 |
Ardelyx Inc
|
Independent Director |
201.9 K |
20.6 % |
2020 |
Ardelyx Inc
|
Independent Director |
167.4 K |
17.9 % |
2019 |
Ardelyx Inc
|
Independent Director |
142.0 K |
56.5 % |
2018 |
Ardelyx Inc
|
Independent Director |
90.7 K |
-1.5 % |
2017 |
Ardelyx Inc
|
Independent Director |
92.1 K |
-52.5 % |
2016 |
Ardelyx Inc
|
Independent Director |
193.7 K |
- |